Mounjaro: New weight reduction drug authorized to be used in Britain to be accessible ‘inside weeks’
An American weight reduction drug authorized in a four-dose injection pen format to be used in Britain might be accessible "within weeks".Mounjaro, also referred to as tirzepatide, is a diabetes drug that was authorised by the Medicines and Healthcare merchandise Regulatory Agency (MHRA) to assist overweight and chubby adults lose and handle weight in November final 12 months.
The authorisation of the US pharmaceutical firm Eli Lilly's Mounjaro "KwikPen" means the corporate will have the ability to "begin supply to the UK within weeks", in accordance with its president and common supervisor of UK and Northern Europe Laura Steele.The Mounjaro KwikPen offers 4 doses of the drug for once-a-week therapy over a month, and has been authorized to deal with adults with kind 2 diabete...









